Cargando…

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group

This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies. Sensitization should be defined using a virtual parameter such as calculated Reaction Frequency (cRF), which assesses HLA antibodies deriv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamode, Nizam, Bestard, Oriol, Claas, Frans, Furian, Lucrezia, Griffin, Siân, Legendre, Christophe, Pengel, Liset, Naesens, Maarten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Health Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399356/ https://www.ncbi.nlm.nih.gov/pubmed/36033645 http://dx.doi.org/10.3389/ti.2022.10511

Ejemplares similares

Alloimmune Risk Stratification for Kidney Transplant Rejection
por: Bestard, Oriol, et al.
Publicado: (2022)

Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation
por: Hilbrands, Luuk, et al.
Publicado: (2022)

European Society for Organ Transplantation (ESOT)-TLJ 3.0 Consensus on Histopathological Analysis of Pre-Implantation Donor Kidney Biopsy: Redefining the Role in the Process of Graft Assessment
por: Zaza, Gianluigi, et al.
Publicado: (2023)

Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions
por: Tong, Allison, et al.
Publicado: (2022)

Surrogate Endpoints for Late Kidney Transplantation Failure
por: Naesens, Maarten, et al.
Publicado: (2022)

Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation
por: Berenguer, Marina, et al.
Publicado: (2023)

Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation
por: Seron, Daniel, et al.
Publicado: (2022)

Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation
por: Roufosse, Candice, et al.
Publicado: (2022)

Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023)

European Society of Organ Transplantation (ESOT) Consensus Statement on Prehabilitation for Solid Organ Transplantation Candidates
por: Annema, Coby, et al.
Publicado: (2023)

ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process
por: Cillo, Umberto, et al.
Publicado: (2022)

Living Donor Kidney Transplantation in Older Individuals: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View
por: Courtney, Aisling E., et al.
Publicado: (2023)

European Society of Organ Transplantation (ESOT) Consensus Report on Downstaging, Bridging and Immunotherapy in Liver Transplantation for Hepatocellular Carcinoma
por: Claasen, Marco Petrus Adrianus Wilhelmus, et al.
Publicado: (2023)

Is Preemptive Kidney Transplantation Associated With Improved Outcomes when Compared to Non-preemptive Kidney Transplantation in Children? A Systematic Review and Meta-Analysis
por: Rana Magar, Reshma, et al.
Publicado: (2022)

The Role of Fc Gamma Receptors in Antibody-Mediated Rejection of Kidney Transplants
por: Delpire, Boris, et al.
Publicado: (2022)

Editorial: Transplant International Goes for GOLD!
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Reflecting on an Intense Year for Transplant International
por: Berney, Thierry, et al.
Publicado: (2022)

The Clinical Utility of Post-Transplant Monitoring of Donor-Specific Antibodies in Stable Renal Transplant Recipients: A Consensus Report With Guideline Statements for Clinical Practice
por: van den Broek, Dennis A. J., et al.
Publicado: (2023)

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation
por: Grossi, Paolo Antonio, et al.
Publicado: (2022)

Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as an Endpoint in Clinical Trials
por: Becker, Jan Ulrich, et al.
Publicado: (2022)

Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement
por: Carbone, M., et al.
Publicado: (2023)

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation
por: Cortesi, Paolo Angelo, et al.
Publicado: (2023)

An Analysis by the European Committee on Organ Transplantation of the Council of Europe Outlining the International Landscape of Donors and Recipients Sex in Solid Organ Transplantation
por: Cozzi, Emanuele, et al.
Publicado: (2022)

Donor Autonomy and Self-Sacrifice in Living Organ Donation: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View
por: Mamode, Nizam, et al.
Publicado: (2022)

The EKiTE network (epidemiology in kidney transplantation - a European validated database): an initiative epidemiological and translational European collaborative research
por: Lorent, M., et al.
Publicado: (2019)

European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy
por: Ferrer-Fàbrega, Joana, et al.
Publicado: (2023)

Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2022)

Equity, Diversity and Inclusion (EDI) in Organ Transplantation: An ESOT Survey About EDI Within ESOT as an Organization and its Educational Activities, and Transplantation Research and Science
por: Pengel, L. H. M., et al.
Publicado: (2023)

Corrigendum: Enteric Budesonide in Transplant and Native IgA Nephropathy: Real-World Clinical Practice
por: Lopez-Martinez, Marina, et al.
Publicado: (2023)

Pre-Kidney Transplant Screening for Coronary Artery Disease: Current Practice in the United Kingdom
por: Nimmo, Ailish, et al.
Publicado: (2022)

Embracing the Wisdom of Ancient Greece in the Era of Personalized Medicine—Uncertainty, Probabilistic Reasoning, and Democratic Consensus
por: Naesens, Maarten
Publicado: (2023)

Dynamic Behaviour of Donor Specific Antibodies in the Early Period Following HLA Incompatible Kidney Transplantation
por: Phillpott, Mason, et al.
Publicado: (2022)

Cytomegalovirus Cell-Mediated Immunity: Ready for Routine Use?
por: Bestard, Oriol, et al.
Publicado: (2023)

A Novel Daratumumab-Based Regimen for Desensitization in Highly HLA-Presensitized Patients Awaiting Kidney Transplantation
por: Zhao, Daqiang, et al.
Publicado: (2023)

HLA antibody testing: a tool to facilitate not to prevent organ transplantation
por: Claas, Frans H J
Publicado: (2008)

When There is No Guidance From the Guidelines: Renal Transplantation in Recipients With Class III Obesity
por: Gillespie, Hannah, et al.
Publicado: (2023)

Complement-Binding Donor-Specific Anti-HLA Antibodies: Biomarker for Immunologic Risk Stratification in Pediatric Kidney Transplantation Recipients
por: Sigurjonsdottir, Vaka K., et al.
Publicado: (2022)

Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5b7c2mvvand5uvhl3f8hnkgave